logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Sleep Initiation And Maintenance Disorders

    FiltersReset Filters
    15 results

    • ambien

      (zolpidem tartrate)
      Cosette Pharmaceuticals, Inc.
      Usage: AMBIEN CR (zolpidem tartrate extended-release tablets) is indicated for the short-term treatment of insomnia, specifically for difficulties with sleep onset and maintenance. Efficacy was established in clinical trials lasting up to 24 weeks.

    • ambien

      (zolpidem tartrate)
      Cosette Pharmaceuticals, Inc.
      Usage: AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia, specifically to help with difficulties in initiating sleep. It has demonstrated effectiveness in reducing sleep latency for up to 35 days based on clinical studies.

    • doxepin hydrochloride

      (Doxepin hydrochloride)
      Novadoz Pharmaceuticals LLC
      Usage: Doxepin tablets are indicated for treating insomnia with difficulty in sleep maintenance, supported by clinical trials lasting up to 3 months.

    • estazolam

      (Estazolam)
      Actavis Pharma, Inc.
      Usage: Estazolam is indicated for the short-term management of insomnia, particularly for difficulties in falling asleep, nocturnal awakenings, and early morning awakenings. It is effective in improving sleep induction and maintenance, with evidence supporting its use for up to 12 weeks. Prolonged use is generally not recommended.

    • eszopiclone

      (ESZOPICLONE)
      Bionpharma Inc.
      Usage: Eszopiclone tablets are indicated for the treatment of insomnia. They effectively decrease sleep latency and improve sleep maintenance, as shown in clinical trials lasting up to 6 months.

    • flurazepam hydrochloride

      (Flurazepam Hydrochloride)
      Chartwell RX, LLC
      Usage: Flurazepam hydrochloride capsules are indicated for treating insomnia, including difficulty falling asleep, frequent awakenings, and early morning awakenings. Short-term use is generally recommended, as prolonged use should involve careful patient evaluation.

    • halcion

      (triazolam)
      Pharmacia & Upjohn Company LLC
      Usage: Halcion is indicated for the short-term treatment of insomnia in adults, typically for a duration of 7 to 10 days.

    • midazolam

      (midazolam hydrochloride)
      Sagent Pharmaceuticals
      Usage: Midazolam Injection is indicated for preoperative sedation, anxiolysis, and amnesia; sedation for diagnostic and therapeutic procedures; induction of general anesthesia; and continuous infusion for sedation in intubated or mechanically ventilated patients in critical care settings.

    • pentobarbital sodium

      (Pentobarbital Sodium)
      Hikma Pharmaceuticals USA Inc. (dba Leucadia Pharmaceuticals)
      Usage: This drug is indicated for use as a sedative, short-term hypnotic for insomnia, preanesthetic, and as an anticonvulsant in emergency situations like status epilepticus and convulsions from cholera, eclampsia, meningitis, tetanus, or toxic reactions.

    • ramelteon

      (Ramelteon)
      Westminster Pharmaceuticals, LLC
      Usage: Ramelteon Tablets are indicated for treating insomnia characterized by difficulty with sleep onset. Efficacy was assessed in clinical trials lasting up to six months, focusing on sleep latency outcomes in both adults and the elderly.